Skip to content
10-Q

Quarterly Report

RESPONSE BIOMEDICAL CORP

0001437749-16-032052

← back to feed
Filed
May 16, 2016 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 2, 2016 9.93M sh
Capex Q1 2016 · Mar 31, 2016 21K
Capex Q1 2016 · Mar 31, 2015 345K
Long Term Debt Q1 2016 · Mar 31, 2016 136K
Long Term Debt Q1 2016 · Dec 31, 2015 357K
Short Term Debt Q1 2016 · Mar 31, 2016 814K
Short Term Debt Q1 2016 · Dec 31, 2015 868K
Cash And Equivalents Q1 2016 · Mar 31, 2016 1.02M
Cash And Equivalents Q1 2016 · Dec 31, 2015 2.51M
Cash And Equivalents Q1 2016 · Mar 31, 2015 1.44M
Cash And Equivalents Q1 2016 · Dec 31, 2014 3.22M
Stockholders Equity Q1 2016 · Mar 31, 2016 −1.7M
Stockholders Equity Q1 2016 · Dec 31, 2015 −711K
Stockholders Equity Q1 2016 · Dec 31, 2014 −894K
Current Liabilities Q1 2016 · Mar 31, 2016 5.98M
Current Liabilities Q1 2016 · Dec 31, 2015 6.39M
Total Liabilities Q1 2016 · Mar 31, 2016 11.66M
Total Liabilities Q1 2016 · Dec 31, 2015 12.47M
Current Assets Q1 2016 · Mar 31, 2016 3.98M
Current Assets Q1 2016 · Dec 31, 2015 5.08M
Total Assets Q1 2016 · Mar 31, 2016 9.97M
Total Assets Q1 2016 · Dec 31, 2015 11.76M
Sga Expense Q1 2016 · Mar 31, 2016 761K
Sga Expense Q1 2016 · Mar 31, 2015 675K
Rd Expense Q1 2016 · Mar 31, 2016 562K
Rd Expense Q1 2016 · Mar 31, 2015 813K
Net Income Q1 2016 · Mar 31, 2016 −1.25M
Net Income Q1 2016 · Dec 31, 2015 −150K
Net Income Q1 2016 · Mar 31, 2015 −1.1M
Gross Profit Q1 2016 · Mar 31, 2016 1.03M
Gross Profit Q1 2016 · Mar 31, 2015 1.36M
Cost Of Revenue Q1 2016 · Mar 31, 2016 1.18M
Cost Of Revenue Q1 2016 · Mar 31, 2015 2.18M
Revenue Q1 2016 · Mar 31, 2016 2.2M
Revenue Q1 2016 · Mar 31, 2015 3.54M